¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"T-cell leukaemia virus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Marburg virus infection
    ¸¶¸£ºÎ¸£±× ¹ÙÀÌ·¯ ½º°¨¿°.
  • Mareks disease virus
    ¸¶·ºº´¹ÙÀÌ·¯½º
  • Marhurg virus
    ¸¶¸£Çã±×¹ÙÀÌ·¯½º
  • Murray valley encephalitis virus
    ¸Ó·¹À̰è°î ³ú¿°¹ÙÀÌ·¯½º
  • Murray valley encephalitis virus
    ¸Ó·¹À̰è°î ³ú¿° ¹ÙÀÌ·¯½º
  • Nebraska calf diarrhea virus
    ³×ºê¶ó½ºÄ« ¼Ò ¼³»ç ¹ÙÀÌ·¯½º
  • Omsk hemorrhagic fever virus
    ¿È½ºÅ© ÃâÇ÷¿­¹ÙÀÌ·¯½º
  • Onyong-nyong virus
    ¿À´¨´¨¹ÙÀÌ·¯½º
  • Orf virus
    ¾ç ¾Æ±¸Ã¢¹ÙÀÌ·¯½º
  • Parainfluenza virus
    ÆÄ¶óÀÎÇ÷翣ÀÚ¹ÙÀÌ·¯½º(¼Ó).
  • Powassan virus
    Æ÷¿Í»ê¹ÙÀÌ·¯½º
  • RNA virus
    RNA¹ÙÀÌ·¯½º.
  • RNA virus
    RNA ¹ÙÀÌ·¯½º
  • Rift Valley fever virus
    ¸®ÇÁÆ® °è°î¿­¹ÙÀÌ·¯½º
  • Rift Valley fever virus
    ¸®ÇÁÆ®°è°î ¿­ ¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bovine leukemia virus
    ¼Ò¹éÇ÷º´¹ÙÀÌ·¯½º
  • bovine papilloma virus
    ¼ÒÀ¯µàÁ¾¹ÙÀÌ·¯½º
  • bovine papular dematitis virus
    ¼ÒÀ¯Ç༺ÇǺο°¹ÙÀÌ·¯½º
  • bovine papular stomatitis virus
    ¼ÒÀ¯Ç༺±¸³»¿°¹ÙÀÌ·¯½º
  • broad bean mottle virus
    ±¤¿ª(ÎÆæ´)¹üÀ§Äá¾ó·è¹ÙÀÌ·¯½º
  • broad bean necrosis virus
    ±¤¿ª(ÎÆæ´)Äᱫ»ç¹ÙÀÌ·¯½º
  • broad bean wilt virus
    ±¤¿ª(ÎÆæ´)ÄáÀ§Ãà¹ÙÀÌ·¯½º
  • burkitts lymphoma,epstein-barr virus
    ¿¦½ºÅ¸ÀÎ-¹Ù ¹ÙÀÌ·¯½º
  • canary pox virus
    Ä«³ª¸®¾Æ¹ßÁøº´¹ÙÀÌ·¯½º
  • canine distemper virus
    °³È«¿ª¹ÙÀÌ·¯½º
  • canine hepatitis virus
    °³°£¿°¹ÙÀÌ·¯½º
  • canine herpes virus
    °³Ç츣Æä½º¹ÙÀÌ·¯½º
  • carrot red leaf virus
    ´ç±Ù ºÓÀºÀÙ¹ÙÀÌ·¯½º
  • cauliflower mosaic virus
    ²É¾ç¹èÃß ¸ðÀÚÀÌÅ©¹ÙÀÌ·¯½º
  • celery mosaic virus
    ¼¿·¯¸® ¸ðÀÚÀÌÅ©¹ÙÀÌ·¯½º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LAV leafhopper A virus; lymphadenopathy-associated virus
LV laryngeal vestibule; lateral ventricle; lecithovitellin; left ventricle, left ventricular; leucovori...
MDV Marek disease virus; mean dye [bolus] velocity; mucosal disease virus
MLV Moloney leukemia virus; multilaminar vesicle; murine leukemia virus
MSV maximum sustained level of ventilation; mean scale value; mean spatial velocity; Moloney sarcoma vir...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ATLL Adult T cell lymphoma/leukaemia
B CLL B chronic lymphocytic leukaemia
BCP ALL B-cell precursor acute lymphoblastic leukaemia
B-PLL B cell prolymphocytic leukaemia
B-PLL B prolymphocytic leukaemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • slow virus infection
    ½½·Î¿ì ¹ÙÀÌ·¯½º °¨¿°
  • T-cell leukemia-lymphoma virus
    T Çü ¼¼Æ÷ ¹éÇ÷º´-ÀÓÆÄÁ¾ ¹ÙÀÌ·¯½º
  • tobacco mosaic virus
    ´ã¹è ¸ðÀÚÀÌÅ© ¹ÙÀÌ·¯½º
    ´ã¹è³ª Å丶Åä µîÀÇ ÀÙ¿¡ £Àº ³ì»öÀÇ ¹ÝÁ¡ÀÌ »ý±â°Å³ª, ÀÙÀ» ÁÙ¾îµé°Ô ÇÏ´Â ¹Ì»ý¹°. 1892³â D. I. À̹ٳëÇÁ½ºÅ°¿¡ ÀÇÇØ¼­ ÃÖÃÊ·Î ¹ß°ßµÇ¾úÀ¸¸ç, 1935³â W. M. ½ºÅĸ®°¡ ÀÌ ¹ÙÀÌ·¯½º¸¦ ħ»ó °áÁ¤À¸·Î ºÐ¸®ÇÏ´Â µ¥ ¼º°øÇÏ¿´´Ù. ¹ÙÀÌ·¯½º ÀÔÀÚ´Â ±æÀÌ 300 nm, Áö¸§ 15 nmÀÇ À°°¢ÇüÀÇ ¸·´ë ¸ð¾çÀÇ °Å´ë ºÐÀÚÀ̸ç, RNA
  • tomato ringspot virus
    Å丶Åä À±Á¡ ¹ÙÀÌ·¯½º
  • tumor virus
    Á¾¾ç ¹ÙÀÌ·¯½º
  • vacuolated virus
    °øÆ÷¼º ¹ÙÀÌ·¯½º
  • variola major virus
    ´ëµÎâ ¹ÙÀÌ·¯½º
    µÎâÀÇ ÁßÁõÇü ÃâÇ÷¼º µÎâÀ̳ª ¾Ç¼º µÎâ µî »ç¸Á·üÀÌ 25-40À¸·Î ³ôÀº °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • variola virus
    ¸¶¸¶ ¹ÙÀÌ·¯½º
  • Venezuelan virus
    º£³×¼ö¿¤¶ó ¹ÙÀÌ·¯½º
    º£³×¼ö¿¤¶ó¿¡¼­ ¸¶³ú¿°À¸·Î Á×Àº µ¿¹°ÀÇ ³ú¿¡¼­ ºÐ¸®µÈ °ÍÀ¸·Î, ¸é¿ªÇÐÀûÀ¸·Î µ¶¸³¼ºÀ» ³ªÅ¸³»¸ç, »ç¶÷¿¡µµ °¨¿°ÇÑ º¸°í°¡ ÀÖ´Ù.
  • verruca virus
    ¿ìÃé ¹ÙÀÌ·¯½º
  • virus
    ¹ÙÀÌ·¯½º
    ¼¼±Õº¸´Ù À۾Ƽ­ ¼¼±Õ ¿©°ú±â·Îµµ ºÐ¸®ÇÒ ¼ö ¾ø°í, ÀüÀÚÇö¹Ì°æÀ» »ç¿ëÇÏÁö ¾ÊÀ¸¸é º¼ ¼ö ¾ø´Â ÀÛÀº ÀÔÀÚ. ºñ·ç½º¶ó°íµµ ÇÑ´Ù. ÀΰøÀûÀÎ ¹èÁö¿¡¼­´Â ¹è¾çÇÒ ¼ö ¾øÁö¸¸ »ì¾Æ ÀÖ´Â ¼¼Æ÷¿¡¼­´Â ¼±ÅÃÀûÀ¸·Î ±âÁõ, Áõ½ÄÇÑ´Ù. ¹ÙÀÌ·¯½º´Â »ýÁ¸¿¡ ÇÊ¿äÇÑ ¹°Áú·Î¼­ ÇÙ»ê
  • virus arthritis
    ¹ÙÀÌ·¯½º °üÀý¿°
  • virus bound antigen
    ¹ÙÀÌ·¯½º °áÇÕ Ç׿ø
  • virus conjunctivitis
    ¹ÙÀÌ·¯½º °á¸·¿°
  • virus culture
    ¹ÙÀÌ·¯½º ¹è¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
myelocytic leukaemia <haematology, tumour> A form of leukaemia characterised by an uncontrolled proliferation of myelopoietic cells in the bone marrow and in extramedullary sites, and the presence of large numbers of immature and mature granulocytic forms in various tissues (and organs) and in the circulating blood.
The total count may range from 1000 (aleukaemic variety) to several hundred thousand per cu mm. The predominant cell is usually of the neutrophilic series, but, in a few instances, eosinophilic or basophilic granulocytes, or even megakaryocytes, may represent the chief form; early in granulocytic leukaemia, the circulating blood may contain excessive numbers of all of the granulocytic forms.
Synonym: leukaemic myelosis, myelocytic leukaemia, myelogenic leukaemia, myelogenous leukaemia, myeloid leukaemia.
(05 Mar 2000)
polymorphocytic leukaemia Granulocytic leukaemia, especially any variety in which the predominant cells are mature, segmented granulocytes.
(05 Mar 2000)
myelomonocytic leukaemia A variant of granulocytic leukaemia with monocytosis in the peripheral blood.
Synonym: Naegeli type of monocytic leukaemia.
(05 Mar 2000)
hairy cell leukaemia <haematology, oncology> A rare chronic disorder characterised by proliferation of hairy cells in reticuloendothelial organs and blood.
Origin: Gr. Haima = blood
(13 Nov 1997)
prolymphocytic leukaemia <haematology> A variant of chronic lymphocytic leukaemia in which the malignant cells have a more immature appearance.
The disease requires chemotherapy and/or radiotherapy and sometimes removal of the spleen (splenectomy).
Origin: Gr. Haima = blood
(13 Nov 1997)
Schilling type of monocytic leukaemia See: monocytic leukaemia.
(05 Mar 2000)
secondary leukaemia A leukaemia arising from either previous chemotherapy or radiotherapy or as the development of a pre-existing condition, such as myelodysplasia.
Origin: Gr. Haima = blood
(13 Nov 1997)
human leukaemia-associated antigens Antigen's on the surface of leukaemic cells which seem not to be present on the surfaces of the same type of normal cells; the myeloblast antigen of acute myelogenous leukaemia found in chronic myelogenous leukaemia is thought to be associated with a "blastic" transformation.
(05 Mar 2000)
smoldering leukaemia A condition in which the bone marrow does not function normally. It does not produce enough blood cells. This condition may progress and become acute leukaemia. Smoldering leukaemia also is called myelodysplastic syndrome or preleukaemia.
(12 Dec 1998)
splenic leukaemia A form of leukaemia in which there is an unusually great degree of enlargement of the spleen, as observed frequently in chronic granulocytic leukaemia.
(05 Mar 2000)
Naegeli type of monocytic leukaemia A variant of granulocytic leukaemia with monocytosis in the peripheral blood.
Synonym: Naegeli type of monocytic leukaemia.
(05 Mar 2000)
stem cell leukaemia A form of leukaemia in which the abnormal cells are thought to be the precursors of lymphoblasts, myeloblasts, or monoblasts.
Synonym: embryonal leukaemia.
(05 Mar 2000)
neutrophilic leukaemia An unusual form of chronic granulocytic leukaemia in which the greatly increased number of leukocytes in the circulating blood are mature polymorphonuclear neutrophils, with virtually no young or immature granulocytes being observed.
(05 Mar 2000)
subleukaemic leukaemia A form of leukaemia in which abnormal cells are present in the peripheral blood, but the total leukocyte count is not elevated.
Synonym: hypoleukaemia, leukopenic myelosis, subleukaemic myelosis, subleukaemia.
(05 Mar 2000)
embryonal leukaemia A form of leukaemia in which the abnormal cells are thought to be the precursors of lymphoblasts, myeloblasts, or monoblasts.
Synonym: embryonal leukaemia.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á